Advertisement

Metabolic Responses to Anti-Cytokine Therapies

  • S. F. Lowry
Part of the Update in Intensive Care and Emergency Medicine book series (UICM, volume 17)

Abstract

Severe injury or invasive infection induce complex alterations of host metabolic and immunologic function. Although it is evident that these are dynamic processes serving as necessary adjuncts to the normal evolution of repair, their propagation may become severely dysfunctional in the setting of complicated injury or organ failure. Despite the clinical application of advanced technology for anti-microbial therapy, organ support, and nutrition, the mechanisms underlying the evolution of such adverse events have generally proven elusive. This discussion will selectively review current understanding of the potential role for inflammatory mediators as proximal determinants of the acute and chronic host metabolic responses to injury or infection. Where possible, observations derived from human systems will be utilized and, additionally, data suggesting the potential influence of anti-cytokine therapies upon these events will be provided.

Keywords

Metabolic Response Mediator System Tumor Necrosis Factor Production Counterregulatory Hormone Neuroendocrine Hormone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lowry SF (1986) The host metabolic response to injury. In: Shires GT, Davis JM (eds) Host defenses Vol. 6, Academic Press, pp. 169–180Google Scholar
  2. 2.
    Cerra FB (1987) Hypermetabolism, organ failure, and metabolic support. Surgery 101:1–14PubMedGoogle Scholar
  3. 3.
    Fong Y, Moldawer LL, Shires GT, Lowry SF (1990) The biological characteristics of cytokines and their implication in surgical injury. Surg Gynecol Obstet 170:363–378PubMedGoogle Scholar
  4. 4.
    Bone RC (1991) The pathogenesis of sepsis. Ann Intern Med 115:457–469PubMedGoogle Scholar
  5. 5.
    Bone RC (1991) A critical evaluation of new agents for the treatment of sepsis. JAMA 266:1686–1691PubMedCrossRefGoogle Scholar
  6. 6.
    Lowry SF, VanZee KJ, Moldawer LL (1992) Strategies for modulation of systemic and tissue cytokine responses to sepsis. In: Lamy M, Thijs LG (eds) Update in Intensive Care and Emergency Medicine, Vol. 16. Mediators of Sepsis. Springer-Verlag, Berlin, Heidelberg, pp. 345–361Google Scholar
  7. 7.
    Lowry SF (1993) Hormone and cytokine regulation of injury metabolism. In: Vincent JL (ed) Yearbook of Intensive Care and Emergency Medicine 1993, pp. 3–11Google Scholar
  8. 8.
    Calvano SE (1986) Hormonal mediation of immune dysfunction following thermal and traumatic injury. In: Davis JM, Shires GT (eds) Advances in host defense mechanisms. Raven Press, New York pp. 111–142Google Scholar
  9. 9.
    Lowry SF (1990) The route of feeding influences injury responses. J Trauma 30:510–515Google Scholar
  10. 10.
    Vassalli P (1992) The pathophysiology of tumor necrosis factors. In: Paul WE, Fathman CG, Metzger H (eds) Annual Review of Immunology, vol. 10. Annual Reviews Inc., Palo Alto pp. 411–452Google Scholar
  11. 11.
    Bessey PQ, Watters JM, Aoki TT, Wilmore DW (1984) Combined hormonal infusion stimulates the metabolic response to injury. Ann Surg 200:264–281PubMedCrossRefGoogle Scholar
  12. 12.
    Gelfand RA, Matthews DE, Bier DM, Sherwin RS (1984) Role of counterregulatory hormones in the catabolic response to stress. J Clin Invest 74:2238–2248PubMedCrossRefGoogle Scholar
  13. 13.
    Stoner HB, Frayn KN, Barton RN, Threlfall CJ, Little RA (1979) The relationships between plasma substrates and hormones and the severity of injury in 277 recently injured patients. Clin Sci 56:563–573PubMedGoogle Scholar
  14. 14.
    Wilmore DW, Long JM, Mason AD, Skreen RW, Pruitt BA (1974) Catecholamines: Mediator of the hypermetabolic response to thermal injury. Ann Surg 180:653–668PubMedCrossRefGoogle Scholar
  15. 15.
    Lowry SF (1992) Modulating the metabolic response to injury and infection. Proc Nutr Soc 51:267–277PubMedCrossRefGoogle Scholar
  16. 16.
    Shaw JHF, Wolfe RR (1985) Alanine, urea, and glucose interrelationship in normal subjects and patients with sepsis with stable isotope tracers. Surgery 97:557–567PubMedGoogle Scholar
  17. 17.
    Shaw JHF, Wildbore M, Wolfe RR (1987) Whole body protein kinetics in severely septic patients. Ann Surg 205:288–294PubMedCrossRefGoogle Scholar
  18. 18.
    Shaw JHF, Wolfe RR (1987) Fatty acid and glycerol kinetics in septic patients and in patients with gastrointestinal cancer. Ann Surg 205:368–376PubMedCrossRefGoogle Scholar
  19. 19.
    Wolfe RR, Herndon DN, Jahoor F, Miyoshi H, Wolfe M (1987) Effect of severe burn injury on substrate cycling by glucose and fatty acids. N Engl J Med 317:403–408PubMedCrossRefGoogle Scholar
  20. 20.
    Shaw JHF, Wolfe RR (1989) An integrated analysis of glucose, fat, and protein metabolism in severely traumatized patients. Ann Surg 209:63–72PubMedCrossRefGoogle Scholar
  21. 21.
    Jahoor F, Shangraw RE, Miyoshi H, Wallfish H, Herndon DN, Wolfe RR (1989) Role of insulin and glucose oxidation in mediating the protein catabolism of burns and sepsis. Am J Physiol 257: E323–E331PubMedGoogle Scholar
  22. 22.
    Fong Y, Albert JD, Tracey KJ, et al (1991) The influence of substrate background on the acute metabolic response to epinephrine and cortisol. J Trauma 31:1467–1476PubMedCrossRefGoogle Scholar
  23. 23.
    Matthews DE, Pesola G, Campbell RG (1990) Effect of epinephrine on amino acid and energy metabolism in humans. Am J Physiol 258 : E948–E956PubMedGoogle Scholar
  24. 24.
    Shaw JHF, Holdaway CM, Humberstone DA (1988) Metabolic intervention in surgical patients: The effect of a or β-blockade on glucose and protein metabolism in surgical patients receiving total parenteral nutrition. Surgery 103:520–525PubMedGoogle Scholar
  25. 25.
    Kraenzlin ME, Keller U, Keller A, Thélin A, Arnaud MJ, Stauffacher W (1989) Elevation of plasma epinephrine concentrations inhibits proteolysis and leucine oxidation in man via β-adrenergic mechanisms. J Clin Invest 84:388–393PubMedCrossRefGoogle Scholar
  26. 26.
    Beaufrere B, Horber FF, Schwenk WF, et al (1989) Glucocorticosteroids increase leucine oxidation and impair leucine balance in humans. Am J Physiol 257:E712–E721PubMedGoogle Scholar
  27. 27.
    Lee MD, Zentella A, Pekala PH, Cerami A (1987) Effect of endotoxin-induced monokines on glucose metabolism in the muscle cell line L6. Proc Natl Acad Sci USA 84:2590–2594PubMedCrossRefGoogle Scholar
  28. 28.
    Warren RS, Starnes HF Jr, Gabrilove JL, Oettgen HF, Brennan MF (1987) The acute metabolic effects of tumor necrosis factor administration in humans. Arch Surg 122:1396–1400PubMedCrossRefGoogle Scholar
  29. 29.
    Starnes HF, Warren RA, Jeevanandam M, et al (1988) Tumor necrosis factor and the acute metabolic response to tissue injury in man. J Clin Invest 82:1321–1325PubMedCrossRefGoogle Scholar
  30. 30.
    Tracey KJ, Fong Y, Hess D, et al (1988) Cachectin (tumor necrosis factora, TNF-α) participates in the metabolic derangements induced by gram-negative bacteremia. Surg Forum 39:8–10Google Scholar
  31. 31.
    Tracey KJ, Lowry SF (1989) The role of cytokines in septic shock. In: Tompkins RK (ed) Advances in surgery. Yearbook Medical Publishers, Chicago pp. 21–56Google Scholar
  32. 32.
    Moldawer LL, Lowry SF, Cerami A (1988) Chachectin: Its impact on metabolism and nutritional status. Ann Rev Nutr 8:585–609CrossRefGoogle Scholar
  33. 33.
    Klasing KC (1988) Nutritional aspects of leukocytic cytokines. J Nutr 118:1436–1446PubMedGoogle Scholar
  34. 34.
    van der Poll T, Romijn JA, Endert E, Born JJJ, Büller HR, Sauerwein HP (1991) Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am J Physiol 261: E457–E465PubMedGoogle Scholar
  35. 35.
    Fong Y, Marano MA, Moldawer LL, et al (1990) The acute splanchnic and peripheral tissue metabolic response to endotoxin in man. J Clin Invest 85:1896–1904PubMedCrossRefGoogle Scholar
  36. 36.
    Tracey KJ, Lowry SF, Fahey TJ, et al (1987) Cachectin/tumor necrosis factor induces lethal septic shock and stress hormone responses in the dog. Surg Gynecol Obstet 164:415–422PubMedGoogle Scholar
  37. 37.
    Evans DA, Jacobs DO, Revhaug A, Wilmore DW (1989) The effects of tumor necrosis factor and their selective inhibition by ibuprofen. Ann Surg 209:312–321PubMedCrossRefGoogle Scholar
  38. 38.
    Rock CS, Coyle SM, Keogh CV, et al (1992) Influence of hypercortisolemia on the acute phase protein response to endotoxin in man. Surgery 112:467–474PubMedGoogle Scholar
  39. 39.
    Barber AE, Coyle SM, Marano MA, et al (1993) Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol 150:1999–2006PubMedGoogle Scholar
  40. 40.
    Fischer E, Marano MA, Barber A, et al (1991) Interleukin-1α administration can replicate the hemodynamic and metabolic responses to sublethal endotoxemia. Am J Physiol 261: R442–R452PubMedGoogle Scholar
  41. 41.
    Fischer E, Marano MA, Van Zee KJ, et al (1992) Interleukin-1 receptor blockade improves survival and hemodynamic performance in E. coli septic shock, but fails to alter host responses to sublethal endotoxemia. J Clin Invest 89:1551–1557PubMedCrossRefGoogle Scholar
  42. 42.
    Rhyne CD, Calvano SE, Richardson RP, et al (1987) Functional immune consequences following in vivo lipopolysaccharide (LPS) administration to normal human subjects are secondary to an alteration of antigen presenting cells. Surg Forum 38:96–98Google Scholar
  43. 43.
    Richardson RP, Rhyne CD, Fong Y, et al (1989) Peripheral blood leukocyte kinetics following in vivo lipopolysaccharide (LPS) administration to normal human subjects: Influence of elicited hormones and cytokines. Ann Surg 210:239–245PubMedCrossRefGoogle Scholar
  44. 44.
    Fischer E, Van Zee KJ, Marano MA, et al (1992) Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood 79:2196–2200PubMedGoogle Scholar
  45. 45.
    VanZee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF (1992) Tumor necrosis factor (TNF) soluble receptors circulate during experimental and clinical inflammation and can protect against excessive TNFa in vitro and in vivo. Proc Natl Acad Sci 89:4845–4849CrossRefGoogle Scholar
  46. 46.
    Schattner A, Steinbock M, Tepper R, Schonfeld A, Vaisman N, Hahn T (1990) Tumour necrosis factor production and cell-mediated immunity in anorexia nervosa. Clin Exp Immunol 79:62–66PubMedCrossRefGoogle Scholar
  47. 47.
    Luger A, Graf H, Schwarz H-P, Stummvoll H-K, Luger TA (1986) Decreased serum interleukin 1 activity and monocyte interleukin 1 production in patients with fatal sepsis. Crit Care Med 14:458–461PubMedCrossRefGoogle Scholar
  48. 48.
    Oliff A, Defeo-Jones D, Boyer M, et al (1987) Tumors secreting human TNF/cachectin induce cachexia in mice. Cell 50:555–563PubMedCrossRefGoogle Scholar
  49. 49.
    Tracey KJ, Fong Y, Hesse DG, et al (1987) Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature 330:662–664PubMedCrossRefGoogle Scholar
  50. 50.
    Ziegler EJ, Fisher CJ Jr, Sprung CL, et al (1991) Treatment of gram-negative bacteremia and septic shock with HA-IA monoclonal antibody endotoxin: A randomized, double-blind, placebo-controlled trial. N Engl J Med 324:429–436PubMedCrossRefGoogle Scholar
  51. 51.
    Munoz C, Carlet J, Fitting C, Misset B, Blériot J-P, Cavaillon J-M (1991) Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 88:1747–1754PubMedCrossRefGoogle Scholar
  52. 52.
    Herndon DN, Stein MD, Rutan TC, Abston S, Linares H (1987) Failure of TPN supplementation to improve liver function, immunity, and mortality in thermally injured patients. J Trauma 27:195–204PubMedCrossRefGoogle Scholar
  53. 53.
    Fong Y, Tracy KJ, Moldawer LL, et al (1989) Antibodies to cachectin/TNF reduce interleukin-1β and interleukin-6 appearance during lethal bacteremia. J Exp Med 170:1627–1633PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • S. F. Lowry

There are no affiliations available

Personalised recommendations